Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
14
×
national blog main
san diego blog main
san diego top stories
boston blog main
boston top stories
fda
national top stories
new york blog main
biotech
clinical trials
new york top stories
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
biontech
boston
deals
eli lilly
healthcare
national
pfizer
san diego
software
boston scientific
bristol-myers squibb
What
time
14
×
fda
deal
approved
based
bio
cancer
catch
comes
company
days
developed
drug
friday
gone
heart
innovation
investors
latest
medical
medicine
mrna
new
patients
real
rna
second
startup
tech
technology
therapeutics
vaccine
venture
watchlist
wi
acquire
acutus
add
adding
adds
Language
unset
unknown
Current search:
time
×
" life sciences "
×
@techcrunch.com
2 years ago
BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
WI Watchlist: Epic, Shine, Venture Investors, Stratatech & More
@xconomy.com
4 years ago
WI Watchlist: E-Scooters, CUNA Incubator, Curate Funding & More
@xconomy.com
4 years ago
Acutus, Maker of Next-Gen Electrophysiology Tech, Adds $100M Series D
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@xconomy.com
5 years ago
No Vital Signs Apparent at Wireless Health Specialist Awarepoint
@techcrunch.com
8 years ago
It’s Time The Tech Industry Paid Attention To The Healthcare Needs Of The Hispanic Community